REG - AstraZeneca PLC - Annual Financial Report <Origin Href="QuoteRef">AZN.L</Origin> - Part 33
08/03/2016 12:10
- Part 33: For the preceding part double click ID:nRSH4027RF
practices asserted by federal and state governmental authorities and
private payers and consumers, which have resulted in substantial expense
and other significant consequences. Note 27 to the Financial Statements
from page 186 describes the material legal proceedings in which we are
currently involved.
Failure to adhere to applicable laws, rules and regulations relating to Impact Where a government authority investigates our adherence to competition laws, or we become subject to private party lawsuits, this may result in inspections of our sites or requests for documents and other information.Competition investigations or legal proceedings could be costly, divert management attention or damage our reputation and demand for our products. Unfavourable resolution of such current and similar future proceedings against us could subject us to fines and penalties,
anti-competitive behaviourAny failure to comply with laws, rules and
regulations relating to anti-competitive behaviour may expose us to
regulatory sanctions and/or lawsuits from governmental authorities and
private, nongovernmental entities.Certain of our commercial arrangements
with generics companies, which have sought to settle patent challenges on
terms acceptable to both innovator and generics manufacturer,
- More to follow, for following part double click ID:nRSH4027RHRecent news on AstraZeneca
See all newsRCS - LHH - LHH, EZRA's AI Leadership Transformation Program
AnnouncementREG - AstraZeneca PLC - Baxdrostat met primary endpoint in Bax24 Ph3 trial
AnnouncementREG - AstraZeneca PLC - Datroway improved OS and PFS in TROPION-Breast02
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Enhertu improved IDFS in early BC in DB-05
Announcement